Reviva Pharmaceuticals Holdings, Inc. Fair Value Adjustment of Warrants
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Fair Value Adjustment of Warrants of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-12
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2026-06-30 was $0.00.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $0.00.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$44.51K, a 500.02% decline year-over-year.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was $27.82K.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2025 was -$89.01K.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2024 was -$717.64K, a 400.00% decline from fiscal 2023.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2023 was $239.22K, a 22.86% increase from fiscal 2022.
- Reviva Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2022 was $194.71K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | -$44.51K derived: sum of 3 quarters · filed 2026-08-12 | -$16.69K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | -$44.51K derived: sum of 2 quarters · filed 2026-05-13 | -$16.69K derived: sum of 3 quarters · filed 2026-05-13 | -$27.82K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$44.51K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$16.69K derived: sum of 2 quarters · filed 2026-03-30 | -$27.82K derived: sum of 3 quarters · filed 2026-08-12 | -$89.01K 10-K · filed 2026-03-30 |
| 2025-09-30 | $27.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $16.69K derived: sum of 2 quarters · filed 2026-08-12 | -$44.50K 10-Q · filed 2025-11-13 | -$33.38K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$11.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$72.32K 10-Q · filed 2026-08-12 | -$61.19K derived: sum of 3 quarters · filed 2026-08-12 | -$133.51K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$61.19K 10-Q · filed 2026-05-13 | -$50.07K derived: sum of 2 quarters · filed 2026-05-13 | -$122.39K derived: sum of 3 quarters · filed 2026-05-13 | -$322.66K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $11.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$61.20K derived: sum of 2 quarters · filed 2026-03-30 | -$261.47K derived: sum of 3 quarters · filed 2026-03-30 | -$717.64K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$72.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$272.59K derived: sum of 2 quarters · filed 2025-11-13 | -$728.77K 10-Q · filed 2025-11-13 | -$795.53K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$200.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$656.45K 10-Q · filed 2025-08-14 | -$723.21K derived: sum of 3 quarters · filed 2025-08-14 | -$862.28K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$456.18K 10-Q · filed 2025-05-15 | -$522.93K derived: sum of 2 quarters · filed 2025-05-15 | -$662.01K derived: sum of 3 quarters · filed 2025-05-15 | -$205.84K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$66.76K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | -$205.84K derived: sum of 2 quarters · filed 2025-04-03 | $250.34K derived: sum of 3 quarters · filed 2025-04-03 | $239.22K 10-K · filed 2025-04-03 |
| 2023-09-30 | -$139.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $317.10K derived: sum of 2 quarters · filed 2024-11-14 | $305.97K 10-Q · filed 2024-11-14 | $767.71K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $456.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $445.05K 10-Q · filed 2024-08-14 | $906.79K derived: sum of 3 quarters · filed 2024-08-14 | $906.79K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$11.13K 10-Q · filed 2024-05-14 | $450.61K derived: sum of 2 quarters · filed 2024-05-14 | $450.61K derived: sum of 3 quarters · filed 2024-05-14 | $272.59K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $461.74K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $461.74K derived: sum of 2 quarters · filed 2024-04-15 | $283.72K derived: sum of 3 quarters · filed 2024-04-15 | $194.71K 10-K · filed 2024-04-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$178.02K derived: sum of 2 quarters · filed 2023-11-14 | -$267.03K 10-Q · filed 2023-11-14 | -$545.19K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$178.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$267.03K 10-Q · filed 2023-08-14 | -$545.19K derived: sum of 3 quarters · filed 2023-08-14 | -$745.46K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$89.01K 10-Q · filed 2023-05-15 | -$367.17K derived: sum of 2 quarters · filed 2023-05-15 | -$567.44K derived: sum of 3 quarters · filed 2023-05-15 | -$756.59K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$278.16K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$478.43K derived: sum of 2 quarters · filed 2023-03-30 | -$667.58K derived: sum of 3 quarters · filed 2023-03-30 | -$1.59M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$200.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$389.42K derived: sum of 2 quarters · filed 2022-11-14 | -$1.31M 10-Q · filed 2022-11-14 | -$1.35M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$189.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.11M 10-Q · filed 2022-08-15 | -$1.15M derived: sum of 3 quarters · filed 2022-08-15 | |
| 2021-03-31 | -$923.48K 10-Q · filed 2022-05-16 | -$964.62K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$41.14K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.08M 10-K · filed 2022-03-15 | ||
| 2020-09-30 | $1.13M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | -$6.41K 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |